|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-04
|
$2,507,598
|
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
|
5R01CA210259-02
|
$667,691
|
|
BULLER, DAVID
|
KLEIN BUENDEL, INC.
|
|
Tumor-associated Physiological Changes Arising from Ras-induced Mitochondrial Fission
|
5F31CA196329-03
|
$31,856
|
|
NASCIMENTO, ALDO
|
UNIVERSITY OF VIRGINIA
|
|
Training providers in CBT plus Hypnosis - an evidence-based fatigue intervention
|
5R25CA193098-04
|
$295,813
|
|
MONTGOMERY, GUY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
|
5R01CA219083-02
|
$368,288
|
|
MOON, EDMUND
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Role of post-translational activation of Myc in pancreatic cancer
|
3R01CA196228-04S1
|
$100,339
|
|
SEARS, ROSALIE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The role of PLAG1 in Wilms tumor formation
|
5K08CA207849-02
|
$156,645
|
|
CHEN, KENNETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
5R01CA201124-03
|
$259,646
|
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Targeting telomerase for melanoma therapeutics
|
5R01CA201312-03
|
$471,448
|
|
SKORDALAKES, EMMANUEL
|
WISTAR INSTITUTE
|
|
Systems Biology of RAS and RAF Oncogenes and Personalized Medicine
|
5K22CA216318-02
|
$194,400
|
|
STITES, EDWARD
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
State Immunization Information Systems to Improve HPV Vaccination Rates
|
5R01CA187707-04
|
$566,188
|
|
SZILAGYI, PETER
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Social networks, breast cancer treatment, and survival
|
5K07CA187403-04
|
$186,893
|
|
KROENKE, CANDYCE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Role of the Histone Modifier KDM2A in Lung Cancer
|
5R01CA207098-02
|
$366,000
|
|
LEE, MIN GYU
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-05
|
$127,865
|
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Role of breast cancer-secreted miRNA in directing a stromal metabolic plasticity
|
5R01CA218140-02
|
$492,142
|
|
WANG, SHIZHEN
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
RIP140 as a mediator of Estrogen Receptor action in tumor associated macrophages
|
5F31CA220978-02
|
$35,725
|
|
ANDREANO, KAITLYN
|
DUKE UNIVERSITY
|
|
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
|
5R01CA218657-02
|
$670,659
|
|
ROSSER, B R SIMON
|
UNIVERSITY OF MINNESOTA
|
|
Quantitative Analysis of GBM Invasion Mechanisms with New Imaging Protocol
|
5K25CA181503-05
|
$120,128
|
|
KONG, JUN
|
EMORY UNIVERSITY
|
|
Prospective immune profiling using methylation markers and pancreatic cancer risk
|
5R01CA207110-03
|
$674,455
|
|
MICHAUD, DOMINIQUE
|
TUFTS UNIVERSITY BOSTON
|
|
Problem Solving Skills Training in Adult Cancer Survivors: Bright IDEAS-AC
|
1R21CA217382-01A1
|
$219,717
|
|
NOYES, EKATERINA
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Probing the role of a highly expressed lncRNA in hepatocellular carcinoma
|
5F31CA220997-02
|
$36,064
|
|
YU, ALLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Predictive experiment-based multiscale models of angiogenesis in breast cancer
|
5R01CA138264-10
|
$526,097
|
|
POPEL, ALEKSANDER
|
JOHNS HOPKINS UNIVERSITY
|
|
Placebo-controlled trial of bupropion for smoking cessation in pregnant women
|
5R01CA184315-05
|
$594,991
|
|
KRANZLER, HENRY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Personalized, Dynamic Risk-based Lung Cancer Screening
|
5F32CA220961-02
|
$59,038
|
|
TOUMAZIS, IAKOVOS
|
STANFORD UNIVERSITY
|
|
Patient Perspectives on the Ethical Implementation of an Oncology Learning System
|
5R01CA201356-03
|
$417,227
|
|
JAGSI, RESHMA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Novel posttranslational modification in LKB1 activation and cancer development
|
5R01CA182424-06
|
$321,625
|
|
LIN, HUI-KUAN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Neuroscience-based Interventions for Cancer Risk Behavior Change
|
5R35CA197461-04
|
$959,990
|
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Narrative visualization for breast cancer survivors physical activity
|
1R21CA218543-01A1
|
$218,883
|
|
LYONS, ELIZABETH
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
|
Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers
|
5U01CA198989-04
|
$575,774
|
|
LIN, WENBIN
|
UNIVERSITY OF CHICAGO
|
|
MRI-Guided Dendritic-Cell-Based Vaccine Immunotherapy for Pancreatic Cancer
|
5R01CA209886-03
|
$352,824
|
|
ZHANG, ZHUOLI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Microenvironmental FGF2-mediated resistance to anti-estrogen and PI3K/mTOR pathway therapeutics in ER+ breast cancer
|
5F30CA216966-02
|
$49,524
|
|
SHEE, KEVIN
|
DARTMOUTH COLLEGE
|
|
Metabolic Profiling in Pediatric Fusion Positive Sarcoma
|
1R21CA220090-01A1
|
$211,410
|
|
LEAVEY, PATRICK
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Mechanisms of Macrophage-Mediated Tumor Metastasis
|
5F30CA200133-05
|
$36,016
|
|
BURKARD, LAUREN
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Live-cell Activity Architecture in Cancer
|
5R35CA197622-04
|
$930,000
|
|
ZHANG, JIN
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
L-type Calcium Channels as PotentialTherapeutic Targets for Melanoma
|
5F30CA216885-02
|
$40,314
|
|
YUAN, WEN-CHENG
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Investigation of Cdc34 Molecular Recognition by its Enzyme Partners, Uba1 and SCF Ligases.
|
5F30CA216921-02
|
$46,430
|
|
WILLIAMS, KATELYN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Investigate peptide-based nanofiber as a multiplexed delivery system to metastatic breast tumors
|
5R03CA219718-02
|
$84,750
|
|
LAW, BENEDICT
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Intra-tumor Heterogeneity in Colorectal Cancer Progression and Treatment Response
|
5K08CA190645-03
|
$174,960
|
|
HARDIMAN, KARIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Interrogating tension-adhesion coupling via high-speed deformation-relaxation
|
1R21CA220202-01A1
|
$184,659
|
|
LIN, HAO
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
Interdisciplinary Training in Cancer Epidemiology at UB
|
5T32CA113951-12
|
$97,463
|
|
FREUDENHEIM, JO
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer
|
5R35CA210030-03
|
$1,046,441
|
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
INCREMENTAL SEVERABLE FUNDING FOR THE NCI AT FREDERICK
|
261200800001E
|
$205,925,847
|
$226
|
HEIMBROOK, DAVID
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment
|
5R01CA198145-03
|
$632,140
|
|
COOPERBERG, MATTHEW
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Implementation of Survivorship Care Plans for Adolescent and Young Adult Survivors of Childhood Cancer: Stakeholder Perspectives of Barriers and Facilitators
|
1R21CA219371-01A1
|
$198,733
|
|
SCHWARTZ, LISA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Immune epigenetic biomarkers of survival in glioma epidemiology
|
5R01CA207360-02
|
$815,423
|
|
WIENCKE, JOHN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Imaging Liver Cancer Proliferation
|
5R01CA204373-03
|
$378,195
|
|
LEE, ZHENGHONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Identification of susceptibility to chemotherapy induced peripheral neuropathy using patient stem cell derived sensory neurons
|
5R03CA220219-02
|
$88,500
|
|
WOOLF, CLIFFORD
|
BOSTON CHILDREN'S HOSPITAL
|
|
HNRNPA2B1 as a reader of RNA methylation in breast cancer
|
1R21CA219252-01A1
|
$178,185
|
|
KLINGE, CAROLYN
|
UNIVERSITY OF LOUISVILLE
|
|
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers
|
1U01CA220714-01A1
|
$583,189
|
|
WILLERS, HENNING
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Gut microbiota mediated bile acid alterations in hepatic carcinogenesis
|
5U01CA188387-04
|
$550,892
|
|
JIA, WEI
|
UNIVERSITY OF HAWAII AT MANOA
|
Total relevant funding to Herpes - Genital for this search: $96,963
|